Transcription of Timetable: Type II variation and worksharing application ...
{{id}} {{{paragraph}}}
The timetables in this document may be subject to revisionType II variation and worksharing application monthly * assessment timetablesInitial submission assessment timetableResponses to Request for Supplementary Information (RSI) assessment timetable* monthly timetables have an outcome during the week of the CHMP meeting30-day after clockstop30-day after immediate responses9 December 202190-day60-day60-day after clockstop30-dayEMA/577385/2016 Medicines DivisionOfficial addressDomenico Scarlattilaan 6 1083 HS Amsterdam The NetherlandsAddress for visits and deliveriesRefer to us a question Go to +31 (0)88 781 6000An agency of the European Union Page 1 / 19 European Medicines Agency, 2021.
Type II variation and worksharing application : monthly * assessment timetables: Initial submission assessment timetable: Responses to Request for Supplementary Information (RSI) assessment timetable * monthly timetables have an outcome during the week of the CHMP meeting 30-day after clockstop
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}